Leerink Swann LLC and Oppenheimer & Co. Inc.
"Leerink Swann LLC and Oppenheimer & Co. Inc. will act as joint book-running managers for the offering." So they obviously intend on roping together various underwriters...
If the underwriting was secured then why make this statement- "The Audeo Fundraising and IPO will only Complete if Audeo Oncology signs an underwriting agreement for an amount, not exceeding US$60 million"
- Forums
- ASX - By Stock
- TSN
- conditions to the demerger
conditions to the demerger, page-4
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online